Abstract
The development of a potent mechanism-based inactivator of NagZ, an enzyme critical to the production of inducible AmpC β-lactamase in Gram-negative bacteria, is presented. This inactivator significantly reduces MIC values for important β-lactams against a clinically relevant strain of Pseudomonas aeruginosa.
Funding Information
  • Cystic Fibrosis Canada
  • Canadian Institutes of Health Research (PJT-148496)
  • Canada Research Chairs
  • Australian Research Council

This publication has 45 references indexed in Scilit: